ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2018

Jan 4, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CIK: 0000879407
Period of Report: 2018-01-01

Reporting Person: GIVEN BRUCE D (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-01-01	Common Stock	A	175000	$0.00	Acquired	948356	Direct
2018-01-01	Common Stock	S	20000	$3.69	Disposed	928356	Direct

Footnotes

F1: Represents shares underlying a restricted stock unit, which shares will vest in four equal annual installments.

F2: Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The sale was made to generate proceeds to cover the tax liability incident to the vesting of restricted stock units on 01/01/2018.